Kiora Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 15.19
| KPRX Stock | USD 3.29 0.06 1.79% |
Kiora |
Kiora Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kiora Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kiora Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kiora Pharmaceuticals generated a negative expected return over the last 90 days | |
| Kiora Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (12.51 M) with loss before overhead, payroll, taxes, and interest of (5.14 M). | |
| Kiora Pharmaceuticals currently holds about 2.43 M in cash with (9.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64. | |
| Kiora Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Kiora Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kiora Stock often depends not only on the future outlook of the current and potential Kiora Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiora Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 538 K | |
| Cash And Short Term Investments | 2.5 M |
Kiora Pharmaceuticals Technical Analysis
Kiora Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Kiora Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kiora Pharmaceuticals. In general, you should focus on analyzing Kiora Stock price patterns and their correlations with different microeconomic environments and drivers.
Kiora Pharmaceuticals Predictive Forecast Models
Kiora Pharmaceuticals' time-series forecasting models is one of many Kiora Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kiora Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kiora Pharmaceuticals
Checking the ongoing alerts about Kiora Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kiora Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kiora Pharmaceuticals generated a negative expected return over the last 90 days | |
| Kiora Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (12.51 M) with loss before overhead, payroll, taxes, and interest of (5.14 M). | |
| Kiora Pharmaceuticals currently holds about 2.43 M in cash with (9.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64. | |
| Kiora Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.